This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Achanta, G. Articles by Huang, P. Search for Related Content PubMed PubMed Citation Articles by Achanta, G. Articles by Huang, P.

Interaction of p53 and DNA-PK in Response to Nucleoside Analogues

Potential Role As a Sensor Complex for DNA Damage¹

Departments of Molecular Pathology [G. A., H. P., L. F., P. H.] and Experimental Therapeutics [W. P.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Therapeutic nucleoside analogues such as ara-C, gemcitabine, and fludarabine exert their cytotoxic activity against cancer cells mainly by incorporation into DNA and disruption of further DNA synthesis, resulting in the triggering of apoptosis. However, the molecules that recognize the incorporated analogues in DNA and subsequently initiate the downstream cellular responses remain to be identified. Here, we report that the DNA-dependent protein kinase (DNA-PK) and p53 are able to form a protein complex that interacts with the gemcitabine-containing DNA and plays a role in signaling to apoptotic pathways. DNA-PK/Ku and p53 were copurified in a protein fraction that binds to gemcitabine-containing DNA in preference to normal DNA. Immunoprecipitation experiments revealed that the two proteins physically associate in a complex. Treatment with gemcitabine resulted in an increase of DNA-PK and p53 protein and an increase in the phosphorylation of p53 at Ser15. Furthermore, confocal microscopy demonstrated a colocalization of DNA-PK and p53 to the nucleus in cells treated with gemcitabine. The nuclear localization of the DNA-PK/p53 complex was coincident with the induction of apoptosis in these cells. Although the wild-type p53 present in the protein complex exhibited 3'-5' exonuclease activity, it was incapable of excising the incorporated gemcitabine from DNA. The binding of the p53/DNA-PK complex to DNA substantially blocked further DNA synthesis by DNA polymerases and in vitro, indicating a stalling of this complex at the site of drug incorporation. These data suggest that DNA-PK and p53 may form a sensor complex that detects the disruption of DNA replication caused by nucleoside analogue incorporation and may subsequently signal for apoptosis.

This article has been cited by other articles:

				N. F. Krynetskaia, M. S. Phadke, S. H. Jadhav, and E. Y. Krynetskiy Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage Mol. Cancer Ther., April 1, 2009; 8(4): 864 - 872. [Abstract] [Full Text] [PDF]

				X. Liu, A. Matsuda, and W. Plunkett Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue 2'-C-cyano-2'-deoxy-1- -D-arabino-pentofuranosylcytosine Mol. Cancer Ther., January 1, 2008; 7(1): 133 - 142. [Abstract] [Full Text] [PDF]

				C.-K. Youn, P. I. Song, M.-H. Kim, J. S. Kim, J.-W. Hyun, S.-J. Choi, S. P. Yoon, M. H. Chung, I.-Y. Chang, and H. J. You Human 8-Oxoguanine DNA Glycosylase Suppresses the Oxidative Stress Induced Apoptosis through a p53-Mediated Signaling Pathway in Human Fibroblasts Mol. Cancer Res., October 1, 2007; 5(10): 1083 - 1098. [Abstract] [Full Text] [PDF]

				V. Heinemann, R. Labianca, A. Hinke, and C. Louvet Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study Ann. Onc., October 1, 2007; 18(10): 1652 - 1659. [Abstract] [Full Text] [PDF]

				S. E. Golding, E. Rosenberg, S. Neill, P. Dent, L. F. Povirk, and K. Valerie Extracellular Signal-Related Kinase Positively Regulates Ataxia Telangiectasia Mutated, Homologous Recombination Repair, and the DNA Damage Response Cancer Res., February 1, 2007; 67(3): 1046 - 1053. [Abstract] [Full Text] [PDF]

				V. Heinemann, D. Quietzsch, F. Gieseler, M. Gonnermann, H. Schonekas, A. Rost, H. Neuhaus, C. Haag, M. Clemens, B. Heinrich, et al. Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer J. Clin. Oncol., August 20, 2006; 24(24): 3946 - 3952. [Abstract] [Full Text] [PDF]

				E.-J. Yeo, J.-H. Ryu, Y.-S. Chun, Y.-S. Cho, I.-J. Jang, H. Cho, J. Kim, M.-S. Kim, and J.-W. Park YC-1 Induces S Cell Cycle Arrest and Apoptosis by Activating Checkpoint Kinases. Cancer Res., June 15, 2006; 66(12): 6345 - 6352. [Abstract] [Full Text] [PDF]

				J. V. Thottassery, L. Westbrook, H. Someya, and W. B. Parker c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-{beta}-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells. Mol. Cancer Ther., February 1, 2006; 5(2): 400 - 410. [Abstract] [Full Text] [PDF]

				S.-J. Lee, D.-C. Kim, B.-H. Choi, H. Ha, and K.-T. Kim Regulation of p53 by Activated Protein Kinase C-{delta} during Nitric Oxide-induced Dopaminergic Cell Death J. Biol. Chem., January 27, 2006; 281(4): 2215 - 2224. [Abstract] [Full Text] [PDF]

				S. Dhanalakshmi, C. Agarwal, R. P. Singh, and R. Agarwal Silibinin Up-regulates DNA-Protein Kinase-dependent p53 Activation to Enhance UVB-induced Apoptosis in Mouse Epithelial JB6 Cells J. Biol. Chem., May 27, 2005; 280(21): 20375 - 20383. [Abstract] [Full Text] [PDF]

				R. Dip and H. Naegeli More than just strand breaks: the recognition of structural DNA discontinuities by DNA-dependent protein kinase catalytic subunit FASEB J, May 1, 2005; 19(7): 704 - 715. [Abstract] [Full Text] [PDF]

				M. Bakhanashvili, E. Novitsky, E. Rubinstein, I. Levy, and G. Rahav Excision of Nucleoside Analogs from DNA by p53 Protein, a Potential Cellular Mechanism of Resistance to Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1576 - 1579. [Abstract] [Full Text] [PDF]

				K. A. Gould, C. Nixon, and M. J. Tilby p53 Elevation in Relation to Levels and Cytotoxicity of Mono- and Bifunctional Melphalan-DNA Adducts Mol. Pharmacol., November 1, 2004; 66(5): 1301 - 1309. [Abstract] [Full Text] [PDF]

				G. Achanta and P. Huang Role of p53 in Sensing Oxidative DNA Damage in Response to Reactive Oxygen Species-Generating Agents Cancer Res., September 1, 2004; 64(17): 6233 - 6239. [Abstract] [Full Text] [PDF]

				C. Jiang, H. Hu, B. Malewicz, Z. Wang, and J. Lu Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells Mol. Cancer Ther., July 1, 2004; 3(7): 877 - 884. [Abstract] [Full Text] [PDF]

				A. M. Kamat, T. Karashima, D. W. Davis, L. Lashinger, M. Bar-Eli, R. Millikan, Y. Shen, C. P. N. Dinney, and D. J. McConkey The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo Mol. Cancer Ther., March 1, 2004; 3(3): 279 - 290. [Abstract] [Full Text]

				D. J. Waxman and P. S. Schwartz Harnessing Apoptosis for Improved Anticancer Gene Therapy Cancer Res., December 15, 2003; 63(24): 8563 - 8572. [Abstract] [Full Text] [PDF]

				J. Yang, Y. Yu, H. E. Hamrick, and P. J. Duerksen-Hughes ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses Carcinogenesis, October 1, 2003; 24(10): 1571 - 1580. [Abstract] [Full Text] [PDF]

				L. Xue, B. Zhou, X. Liu, W. Qiu, Z. Jin, and Y. Yen Wild-Type p53 Regulates Human Ribonucleotide Reductase by Protein-Protein Interaction with p53R2 as well as hRRM2 Subunits Cancer Res., March 1, 2003; 63(5): 980 - 986. [Abstract] [Full Text] [PDF]

				E. Y. Krynetski, N. F. Krynetskaia, M. E. Bianchi, and W. E. Evans A Nuclear Protein Complex Containing High Mobility Group Proteins B1 and B2, Heat Shock Cognate Protein 70, ERp60, and Glyceraldehyde-3-Phosphate Dehydrogenase Is Involved in the Cytotoxic Response to DNA Modified by Incorporation of Anticancer Nucleoside Analogues Cancer Res., January 1, 2003; 63(1): 100 - 106. [Abstract] [Full Text] [PDF]

				C. Melle and H.-P. Nasheuer Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase {alpha}-primase Nucleic Acids Res., April 1, 2002; 30(7): 1493 - 1499. [Abstract] [Full Text] [PDF]